Status:
COMPLETED
Blood Bioavailability of Two Different Doses of a β-alanine Supplement (BIo-β)
Lead Sponsor:
Universidad Católica San Antonio de Murcia
Conditions:
Bioavailability
Eligibility:
MALE
18-60 years
Phase:
NA
Brief Summary
The purpose of this study is to To study the blood bioavailability of a sustained-release β-alanine granulated supplement of two different doses (10 g and 20 g).
Detailed Description
Subjects will consume 10 g of β-alanine one day by 4 ingestions of 2.5 g separated by 1 hour and 15 min. While on another day 20 g of β-alanine by 4 ingestions of 5 g separated by 1 hour and 15 minute...
Eligibility Criteria
Inclusion
- Men between 18 and 60 years old.
- Cyclists with more than two years of cycling experience.
- Bicycle training at least twice a week.
Exclusion
- Suffer a lasting injury that prevents you from training in the month prior to surgery.
- Subjects with a chronic illness.
- Having consumed in the three months prior to the start of the study any β-alanine supplement.
- Making changes in diet or exercise during the study.
- Inability to understand the informed consent form.
- Consumption of other supplements that could alter the results of the study.
Key Trial Info
Start Date :
February 12 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 15 2024
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT06214338
Start Date
February 12 2024
End Date
April 15 2024
Last Update
May 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Catholic University of Murcia
Murcia, Spain, 30107